Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 14 | 155 | 374 | 181 | 11 |
| Gross Profit | 14 | 155 | 374 | 181 | 11 |
| Operating Expenses | 42,649 | 29,896 | 26,325 | 29,334 | 12,239 |
| Operating Income | -42,635 | -29,741 | -25,951 | -29,153 | -12,228 |
| Other Income | 553 | -267 | -1,348 | -1,187 | 129 |
| Pre-tax Income | -42,082 | -30,008 | -27,299 | -30,340 | -12,099 |
| Net Income Continuous | -42,082 | -30,008 | -27,299 | -30,340 | -12,099 |
| Net Income | $-42,082 | $-30,008 | $-27,299 | $-30,340 | $-12,099 |
| EPS Basic Total Ops | -2.11 | -1.67 | -1.52 | -1.88 | -1.01 |
| EPS Basic Continuous Ops | -2.11 | -1.67 | -1.52 | -1.88 | -1.01 |
| EPS Diluted Total Ops | -2.11 | -1.67 | -1.52 | -1.88 | -1.01 |
| EPS Diluted Continuous Ops | -2.11 | -1.67 | -1.52 | -1.88 | -1.01 |
| EPS Diluted Before Non-Recurring Items | -2.11 | -1.67 | -1.52 | -1.88 | -1.01 |
| EBITDA(a) | $-42,556 | $-29,517 | $-25,712 | $-29,027 | $-12,228 |